Dr Zachary Bregman, MD | |
121 W 20th St, Lower Level, New York, NY 10011-3641 | |
(212) 505-6663 | |
(212) 505-9542 |
Full Name | Dr Zachary Bregman |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 43 Years |
Location | 121 W 20th St, New York, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083778716 | NPI | - | NPPES |
NP952 | Other | OXFORD | |
008490 | Other | AETNA | |
2C7045 | Other | HEALTHNET | |
4257353 | Other | AETNA | |
133782328 | Other | CIGNA HEALTHCARE | |
07E301 | Other | EMPIRE BCBS | |
133782325 | Other | UNITED |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | 151294 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lenox Hill Hospital | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Shore - Lij Medical Pc | 3375701568 | 5099 |
News Archive
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
Skillful surgeons can do amazing things in extremely small places, but finding better ways to suture tiny blood vessels has been an ongoing challenge for even the best.
Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain.
CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
› Verified 5 days ago
Entity Name | North Shore - Lij Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
Skillful surgeons can do amazing things in extremely small places, but finding better ways to suture tiny blood vessels has been an ongoing challenge for even the best.
Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain.
CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Zachary Bregman, MD 121 W 20th St, Lower Level, New York, NY 10011-3641 Ph: (212) 505-6663 | Dr Zachary Bregman, MD 121 W 20th St, Lower Level, New York, NY 10011-3641 Ph: (212) 505-6663 |
News Archive
Prostate cancer researchers have drawn a molecular portrait that provides the first complete picture of localized, multi-focal disease within the prostate and also unveils a new gene subgroup driving it.
Skillful surgeons can do amazing things in extremely small places, but finding better ways to suture tiny blood vessels has been an ongoing challenge for even the best.
Researchers at McMaster University have discovered a solution to a long-standing medical mystery in Huntington's disease (HD). HD is a brain disease that can affect 1 in about 7,000 people in mid-life, causing an increasing loss of brain cells at the centre of the brain.
CEL-SCI Corporation reports financial results for the fiscal quarter ended December 31, 2012.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
› Verified 5 days ago
Dr. Ravishankar Ramaswamy, MD, MS Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Dr. Sharon Uralil, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293 | |
Diana Kantor, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |